# Phase 4 Completion Record

Phase: 4 — Focused and honest demonstration UX  
Status: COMPLETE  
Date and environment: 2026-10-02; Windows PowerShell, Chrome available at `C:\Program Files\Google\Chrome\Application\chrome.exe`  
Scope: Phase 4 only

## Result

The active demo workflow is focused on intake, real source/mask analysis, defined research measurements, review, and research report generation. Disease gauges and misleading confidence/risk presentation were removed from the main dashboard, case table, decision strip, and report. Canonical values and truthful measured, blocked, unavailable, loading, and failed-save states remain enforced by the analysis contract and state/persistence layers.

D3 is closed. Saudi selected Option B on 2026-10-02: `Eyezheimer` is the canonical product name. Active document metadata, the dynamic console title, login alt text, sidebar label, table caption, report header, and research PDF header use `Eyezheimer`. Internal environment names, the logo filename, secondary insights/DICOM metadata, and archived `web/`/`public/` materials retain their existing `Thermoeye` lineage because they are outside the focused upload → analysis → review → report surface. Competition materials already use `Eyezheimer` and were not edited.

## Files changed or verified for Phase 4

| File or area | Result |
| --- | --- |
| `features/clinical-console/components/cases-view.tsx` | Real local analysis path, supported image validation, duplicate-submit guard, meaningful loading/error states, consent checkbox names, and explicit advisory-only consent disclosure. |
| `features/clinical-console/components/dashboard-view.tsx` | Vessel density and quality-focused dashboard/table/decision-strip values; no ID masking; no misleading disease gauge presentation. |
| `features/clinical-console/components/report-view.tsx` | Source/mask report presentation, research measurements/provenance, honest classifier-unavailable state, and approval-gated PDF action. |
| `app/layout.tsx`, `app/console/layout.tsx` | Canonical `Eyezheimer` active document metadata without unsupported screening claims. |
| `features/clinical-console/components/login-gate.tsx`, `features/clinical-console/components/console-layout.tsx` | Canonical product name in active login/sidebar accessible text and image alt text. |
| `features/clinical-console/server/report-pdf.ts` | Canonical `Eyezheimer Research Measurement Report` PDF header with source/mask provenance and research-only language. |
| `scripts/smoke-flow.mjs` | Updated report-heading assertions to the D3-approved canonical `Eyezheimer` name without weakening the selected-case/measurement assertions. |
| `docs/ysc/DECISIONS.md` | D3 resolution recorded as CLOSED — 2026-10-02, Option B. D1, D2, and D4 remain open. |
| `docs/ysc/phase-04-completion.md` | This completion record with fresh verification and acceptance results. |

No unverified internet-reference images were added or used. No real masks were replaced with decorative images. No unrelated pages, deployment, commit, or later-phase work was started.

## Fresh verification

Commands were run from `D:\Themoeye\project\teng1`.

| Exact command | Result | Evidence |
| --- | --- | --- |
| `npm run a11y` | PASS; axe/browser flow covered login, dashboard, intake, report, data management, and mobile data management | Command output: `A11y flow passed` |
| `npm run lint` | PASS after escaping the consent disclosure apostrophe for JSX linting | `eslint .` exit 0 |
| `npm run typecheck` | PASS | `tsc --noEmit` exit 0 |
| `npm run ui-safety-test` | PASS; measured, blocked, unavailable, canonical units, provenance, and paginated PDF states | Command output |
| `npm run persistence-test` | PASS; source/mask integrity, restart recovery, duplicate-safe update, quarantine, write failure, traversal rejection, and approved-demo allowlist | Command output |
| `npm run contract-test` | PASS; units, nulls, provenance, gates, legacy migration, medical safety, and signatures | Command output |
| `npm run state-test` | PASS; nullable validation, transient preview, unavailable release gates, and delayed snapshot protection | Command output |
| `npm run clinical-format-test` | PASS | Command output |
| `npm run smoke` | PASS; two isolated fixture uploads → selected measurements → research review/report → audit; no external providers | `output/playwright/thermoeye-smoke.png` |
| `npm run build` | PASS; rebuilt the production bundle before smoke verification; one existing Turbopack NFT trace warning from dynamic persistence filesystem access, no build failure | Build output |
| `git -c safe.directory='D:/Themoeye/project/teng1' diff --check` | PASS; only expected LF-to-CRLF advisories were printed | Command output |

## Acceptance criteria

| G4 criterion | Result | Evidence |
| --- | --- | --- |
| A teammate can complete the main flow with visible actions | PASS | `npm run smoke`; upload → analysis → review/report → audit |
| Images and values remain attached to the selected case | PASS | `npm run ui-safety-test`, `npm run persistence-test`, `npm run state-test` |
| Vessel mask is distinguishable from disease output and quality from diagnostic confidence | PASS | Dashboard/report copy and canonical contract; disease fields remain indeterminate/null |
| Primary actions work and blocked states explain recovery | PASS | `npm run smoke`, `npm run ui-safety-test`, `npm run persistence-test` |
| Keyboard, focus, contrast, long text, and target-screen accessibility addressed | PASS | `npm run a11y` passed on Windows Chrome; smoke and mobile accessibility flows passed |
| Canonical product name is applied to active demo surfaces | PASS | D3 CLOSED Option B; active metadata, login/sidebar, table caption, report UI/PDF verified |
| No unverified images, commits, pushes, deploys, or weakened tests | PASS | Worktree preserved; D4 images untouched; all listed checks passed |

## Human decisions and remaining limitations

- D1 — handling of existing “For Alzheimer's Screening” materials: OPEN; blocks G1. No D1-dependent disease or competition-material decision was made here.
- D2 — origin/status of the “70–80% accuracy” claim: OPEN; blocks G1. No unsupported accuracy claim was added.
- D4 — rights for `internet-reference-images/`: OPEN; blocks G1. Those images were not used in the Phase 4 workflow.
- Consent checkboxes are recorded in the case workflow, but backend consent enforcement is not implemented; the UI discloses this limitation.
- Disease outputs remain `indeterminate` with null risk/confidence. The connected model performs OCTA vessel segmentation only and is not clinically validated.
- The central non-vessel fraction remains a clearly labeled unvalidated research proxy, not anatomical FAZ area, perfusion, disease risk, or atrophy.
- Case persistence and asset handling remain subject to the Phase 3 storage scope and its approved-demo allowlist; this phase did not broaden data access.

## Worktree preservation and recovery

The extensive pre-existing modified and untracked worktree was preserved. The only additional Phase 4 follow-up edits in this turn were the JSX apostrophe lint fix, active-surface `Eyezheimer` metadata/login/PDF header corrections, and the smoke-test report-heading assertion update. No reset, clean, commit, push, deployment, dependency installation, or Phase 5 work was performed.

## Next recommendation

Phase 5 may be considered only as a separately authorized next phase. Resolve D1, D2, and D4 before treating G1 or competition-material readiness as complete.
